Biology

Biomarkers for early detection of Alzheimer’s disease: microRNAs

Systemic inflammation and reduced cerebral Aβ clearance triggered by pancreatic amylin

Long-term transdermal nicotine for the treatment of mild cognitive impairment

The role of p53 in the pathogenesis of Alzheimer’s disease

Targeting cellular senescence in tauopathies

Viral-mediated gene therapy for neurodegenerative disease

Improving the precision and safety of CRISPR/Cas genome editing

Targeting neuroinflammation: identifying new targets using transcriptomics

State of microglial and inflammatory markers in the AD field

How does exercise affect cognition?

The neurogenesis hypothesis: NA-831 for the treatment of Alzheimer’s disease

Discovery and validation of novel drug targets involved in neuroinflammation

Investigational S2R modulator CT1812 affects key proteins in Alzheimer’s disease

Neurotoxic versus neuroprotective astrocytes: is it that simple?

What contributes to hyperexcitability in Alzheimer’s disease?

Boosting ketone levels for brain function: human studies